NAVB: Message Board for Navidea Biopharmaceuticals, Inc. - InvestorVillage


Navidea Biopharmaceuticals, Inc.

  NAVB website

NAVB   /  Message Board

 
BOARD

GROUPS
 





 
Loading...
 
 
--




Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
MSG # SUBJECT TYPE AUTHOR SENTIMENT RECS DATE POSTED
36198 Macrophage M1/M2 polarization plays key role in transplant rejection and therapeutics repolarization may be key to alleviate rejection: U.S. Spain and China 2020 and 2022 GN moneyonomics 4 1/15/2022 2:58:20 PM
36197 Re: Shkreli Banned from Pharma Industry for Life, Ordered to Pay $64.6M Would like to see MG get MORE of the same EOM GN deut8:18 4 1/14/2022 5:26:53 PM
36196 Shkreli Banned from Pharma Industry for Life, Ordered to Pay $64.6M GN Fall1980 7 1/14/2022 5:10:45 PM
36195 Starting to get a pretty good idea of what it must have felt like to be Wile E. Coyote... GN LVoptimist 2 1/14/2022 3:32:18 PM
36194 Back to $1 GN Themonster 0 1/14/2022 2:41:38 PM
36193 Major step for imaging/therapeutics revealed in upgraded 1-13-2022 A1 Patent App. significantly advances Tilmanocept Backbone chemical process...avoids chelator cross linking-weight increase..Protects liver and provide for/stabilize for TAMS, etc targets GN moneyonomics 7 1/13/2022 10:14:38 PM
36192 Navidea was granted fast track SBIR designation (preluded to combine P1/P2) on KS, including both imaging and therapeutics, which funded/greatly advanced the MT-1000 constructs such as MAN-DOX ie which rolls over into other indications GN moneyonomics 4 1/13/2022 5:20:22 PM
36191 Re: Germany 2022. Patients and rheumatologists frustrated/confused at guessing on assessing DMARD RA treatment responses/regimes...need help! ..or right up Navidea's RA diagnostic targeting platform GN co3aii 5 1/13/2022 2:00:12 PM
36190 Germany 2022. Patients and rheumatologists frustrated/confused at guessing on assessing DMARD RA treatment responses/regimes...need help! ..or right up Navidea's RA diagnostic targeting platform GN moneyonomics 8 1/13/2022 1:54:49 PM
36189 Re:Macrophage targeting in cancer...BEING FUNDED NOW: Jan 10 Moderna to provide $80mm to private company Carisma...NAVB asks Why then do we not even have an application for FDA Fast Track? GN moneyonomics 2 1/13/2022 1:20:25 PM
Previous 2500 Messages Top of Message List Post Message Go to Msg #  


Financial Market Data provided by
.
Loading...